WORKED OFF THE FIRST LEG

21 Tem 2017

THIS BIOTECH HAD A MONSTER MOVE FROM 5 TO 17 BEFORE COMING BACK TO EARTH. IT HAS SOME HIGH OCTANE PARTNERS LIKE PFIZER AND IS IN SEVERAL CLINICAL TRIALS. VOLUME DECLINED ON THE SELLOFF AND THE STOCK HAS BEEN RIDING THE 50 DAY m.a.AND JUST CLOSED ABOVE THE 13 DAY. THE OPTIONS HAVE ZERO OPEN INTEREST OR LIQUIDITY. i AM ALREADY LONG FROM $12 AND MISSED MY OPPORTUNITY TO AVERAGE DOWN. I'D BE SURPRISED IF IT DOESN'T TEST $13.41. THE HIGH CLOSE IS $14 AND THEN WHO KNOWS....